AR
FPRX

Advisory Research’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Advisory Research’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-27,281
Closed -$1.37M – 429
2016
Q4 		$1.37M Buy
+27,281
New +$1.37M 0.02% 248